Argentina establishes material for evaluation of amiodarone hydrochloride
This article was originally published in SRA
The Argentinian National Medicines, Food and Medical Technology Administration, Anmat, has issued a regulation establishing the primary reference substance for physicochemical evaluations of the antiarrhythmic drug, amiodarone hydrochloride1.
You may also be interested in...
The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.
No device-related warning letters were released by the US FDA the week of 26 January.
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.